載入...
Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse Sepsis
Cytotoxic T lymphocyte (CTL) activation contributes to liver damage during sepsis, but the mechanisms involved are largely unknown. Understanding the underlying principle will permit interference with CTL activation and thus, provide a new therapeutic option. Methods: To elucidate the mechanism lead...
Na minha lista:
| 發表在: | Theranostics |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Ivyspring International Publisher
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6485280/ https://ncbi.nlm.nih.gov/pubmed/31037153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.28057 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|